in this issue
Regions :: India/Pakistan
Shasun completes US and Mexican regulatory inspections of Cuddalore API plant
11:08 AM MDT | July 8, 2014 | Natasha Alperowicz
Shasun Pharmaceuticals (Chennai, India) said today that it has successfully completed both US FDA and Mexican Cofepris regulatory inspections at its active pharma ingredients facility at Cuddalore, Tamil Nadu State, India. The FDA audit was held in the second week of June and the Cofepris audit by APIF during the last week of June. The FDA inspectors conclude that the facility, systems, and practices comply with FDA requirements, and, when done the inspection, APIF concluded that Shasun’s compliance with cGMP are fully met and that...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: